New Computational Model Predicts Drug Combinations That Account for Microbiome Effects

◇ RESEARCH

Researchers developed a microbiome-aware framework combining machine learning and metabolic models to predict synergistic drug combinations for colorectal cancer in the presence of Fusobacterium nucleatum and other microbes. (Cell Rep Methods)